globenewswire news
2026-08-17T05:45:56Z
Oslo, 17 August 2026: The Board of Directors of Zelluna ASA (the “Company”) hereby calls for an Extraordinary General Meeting to be held on 9 September 2026 at 13:00 CEST,...
2026-08-17T05:35:00Z
PRESS RELEASE
2026-08-17T05:00:00Z
August 17, 2026, 7:00 AM CET
2026-08-17T01:07:42Z
DUBAI, United Arab Emirates, Aug. 17, 2026 (GLOBE NEWSWIRE) -- With demand for aesthetic treatments continuing to rise across the UAE, women are increasingly seeking procedures of breast augmentation in...
2026-08-17T00:35:23Z
NEW YORK, Aug. 16, 2026 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, today announced that it has completed patient treatment in...
2026-08-17T00:00:00Z
— First global Phase III trial to show significant progression-free and overall survival benefits in this setting —
2026-08-14T22:30:00Z
Gross margin improves to 57%, supported by 48% quarterly growth in proprietary product salesQUIX™ rapid-onset portfolio prepared for Q3 launch with more than 35 commercial listings secured
2026-08-14T21:15:00Z
ASCO 2026 Data Demonstrate Long-term Survival Benefit of Plinabulin/Docetaxel and Pembrolizumab in Metastatic NSCLC Following Progression on First-Line Immune Checkpoint Inhibitor (ICI) Therapy
2026-08-14T21:00:00Z
HOUSTON, Aug. 14, 2026 (GLOBE NEWSWIRE) -- Baylor Genetics recently identified a cybersecurity incident that impacted a limited portion of its information technology environment and certain individuals’ personal information. Upon...
2026-08-14T21:00:00Z
BOSTON, Aug. 14, 2026 (GLOBE NEWSWIRE) -- GuideAI Health Corp. ("GuideAI" or the "Company") (Cboe CA: GDAI) (FSE: ZN0) is pleased to announce its common shares are now posted on...
2026-08-14T20:55:00Z
VANCOUVER, British Columbia, Aug. 14, 2026 (GLOBE NEWSWIRE) -- Optimi Health Corp. (NASDAQ: OPTH) (CSE: OPTI) (FSE: 8BN) (the “Company” or “Optimi”), a commercial-stage pharmaceutical manufacturer of regulated psychedelic drug...
2026-08-14T20:50:00Z
MINNEAPOLIS, MN, US, Aug. 14, 2026 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (OTCQX: PETV), in cooperation with its wholly owned subsidiaries, Cosmeta Corp, PetVivo Animal Health, Inc. and PetVivo AI,...
2026-08-14T20:32:58Z
WATERTOWN, Mass., Aug. 14, 2026 (GLOBE NEWSWIRE) -- EyePoint, Inc. (Nasdaq: EYPT), a company committed to developing and commercializing therapeutics to help improve the lives of patients with serious retinal...
2026-08-14T20:30:00Z
NEWTOWN, Pa., Aug. 14, 2026 (GLOBE NEWSWIRE) -- Traws Pharma, Inc. (NASDAQ: TRAW) (“Traws Pharma”, “Traws” or “the Company”), a clinical-stage biopharmaceutical company developing novel therapies to target critical threats...
2026-08-14T20:30:00Z
TORONTO, Aug. 14, 2026 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets innovative interventional MRI (iMRI) procedures,...
2026-08-14T20:28:58Z
Quarter highlighted by steadily increasing patient demand for Vivos’ differentiated array of highly effective OSA treatments
2026-08-14T20:25:00Z
PHILADELPHIA, Aug. 14, 2026 (GLOBE NEWSWIRE) -- Solana Company (NASDAQ: HSDT) (the “Company” or “HSDT”), a publicly listed digital asset treasury, infrastructure, and services company providing institutional access to the...
2026-08-14T20:15:00Z
HOUSTON, Aug. 14, 2026 (GLOBE NEWSWIRE) -- Cerenome, Inc. (Nasdaq: CNSY) ("Cerenome" or the "Company"), a CNS oncology company advancing an integrated platform that combines precision diagnostics, targeted therapeutics, and...
2026-08-14T20:05:00Z
ZUG, Switzerland, Aug. 14, 2026 (GLOBE NEWSWIRE) -- The attached notifications relate to the vesting and settlement of RSUs previously granted to directors of the Company.
2026-08-14T20:05:00Z
EMERYVILLE, Calif., Aug. 14, 2026 (GLOBE NEWSWIRE) -- 4D Molecular Therapeutics (Nasdaq: FDMT, 4DMT or the Company), a leading late-stage biotechnology company advancing durable and disease-targeted therapeutics with potential to...
2026-08-14T20:05:00Z
CAMBRIDGE, Mass., Aug. 14, 2026 (GLOBE NEWSWIRE) -- Korro Bio, Inc. (Korro) (Nasdaq: KRRO), a biopharmaceutical company leveraging a novel Oligonucleotide Promoted Editing of RNA (OPERA®) platform to develop a...
2026-08-14T20:05:00Z
POMPANO BEACH, Fla., Aug. 14, 2026 (GLOBE NEWSWIRE) -- BioStem Technologies Inc. (Nasdaq: BSEM) (“BioStem” or the “Company”), a leading regenerative medicine company focused on the development, manufacturing, and commercialization...
2026-08-14T20:05:00Z
-- $30 million financing enables execution of U.S. commercial strategy for the FemaSeed® fertility portfolio and advancement of the FemBloc® clinical and regulatory program toward U.S. approval --ATLANTA, Aug. 14, 2026...
2026-08-14T20:05:00Z
On Track to Complete Enrollment of Phase 3 ELAINE-3 Clinical Trial of Lasofoxifene in ER-positive (ER+), HER2-negative, ESR1-mutated Metastatic Breast Cancer in 4Q 2026 with Topline Data Expected in 2H...
2026-08-14T20:05:00Z
BOSTON, Aug. 14, 2026 (GLOBE NEWSWIRE) -- Cue Biopharma, Inc. (Nasdaq: CUE), a clinical stage biopharmaceutical company targeting transformative therapies for immune-mediated diseases, today reported second quarter 2026 financial results...
2026-08-14T20:00:00Z
Revenue reaches quarterly record as Precipio returns to positive Adjusted EBITDA and strengthens cash position
2026-08-14T19:47:06Z
WASHINGTON, Aug. 14, 2026 (GLOBE NEWSWIRE) -- 60 Degrees Pharmaceuticals, Inc. (NASDAQ: SXTP; SXTPW) (the “Company”), a pharmaceutical company focused on developing new medicines for vector-borne diseases, reported today its...
2026-08-14T19:15:00Z
MIRAMAR, Fla., Aug. 14, 2026 (GLOBE NEWSWIRE) -- HCW Biologics Inc. (the “Company” or “HCW Biologics”) (NASDAQ: HCWB), a clinical-stage biopharmaceutical company focused on developing transformative fusion immunotherapeutics to treat...
2026-08-14T17:31:57Z
2026 Ford F-250 Super Duty King Ranch and $40,000 cash headline the charity’s latest fundraiser to end childhood blindness
2026-08-14T16:45:00Z
SAN DIEGO, Aug. 14, 2026 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (Nasdaq: DARE), a purpose-driven health biotech company solely focused on closing the gap in women’s health between promising science...
2026-08-14T16:00:00Z
SACRAMENTO, Calif., Aug. 14, 2026 (GLOBE NEWSWIRE) -- During the month of August, Sierra Donor Services (SDS) and Donate Life California recognize National Multicultural Donor Awareness Month by honoring the diverse...
2026-08-14T15:00:00Z
ALBUQUERQUE, N.M., Aug. 14, 2026 (GLOBE NEWSWIRE) -- During the month of August, Sierra Donor Services New Mexico recognizes National Multicultural Donor Awareness Month by honoring the diverse donor heroes in...
2026-08-14T15:00:00Z
Acquisition of Kira Pharmaceuticals closed in July creating a combined company with a robust portfolio of clinical stage assets focused on immunologically-driven disorders
2026-08-14T14:07:00Z
Ohio-born cannabis company's products and experience now available at new East Livingston Avenue dispensary in Reynoldsburg
2026-08-14T14:00:00Z
NASHVILLE, Tenn., Aug. 14, 2026 (GLOBE NEWSWIRE) -- During the month of August, Tennessee Donor Services and Donate Life Tennessee recognize National Multicultural Donor Awareness Month by honoring the diverse donor...
2026-08-14T13:33:25Z
Companies to hold a joint conference call on August 14, 2026 at 10 a.m. ET
2026-08-14T13:32:57Z
– Perceptive Advisors provides approximately $7.0 million of additional investment to further support strategic growth initiatives including CGM+, Trinovium and the Company’s business transformation –
2026-08-14T13:15:00Z
Revenue increase and operating performance improve as capital-efficient distribution strategy gains momentum
2026-08-14T13:00:00Z
PLAINVIEW, N.Y., Aug. 14, 2026 (GLOBE NEWSWIRE) -- Vaso Corporation (“Vaso”) (OTCQX: VASO), a leading MedTech company with a business portfolio in professional sales services and proprietary non-invasive medical products,...
2026-08-14T12:59:00Z
Tissue analysis showed significantly higher numbers of myelin-positive cells in ExoPTEN-treated animals compared with controls, providing additional preclinical biological support for previously reported functional recovery
2026-08-14T12:45:00Z
Successfully transitioned SIL204 from regulatory preparation into an active Phase 2/3 clinical program in locally advanced pancreatic cancer, with trial initiation at Tel Aviv Sourasky Medical Center in July 2026...
2026-08-14T12:45:00Z
Call scheduled for today, Friday, August 14, 2026, at 5:00 pm ET
2026-08-14T12:35:00Z
Among Recent Developments:
2026-08-14T12:32:25Z
Exploratory analyses of patients with very severe social anxiety disorder demonstrated nominally statistically significant improvement in recently reported clinical studies
2026-08-14T12:32:00Z
Strategic project expands Zorronet’s presence in defense technology test and evaluation environments and includes site infrastructure, systems integration, a dedicated command-and-control center and coordination with adjacent testing facilities
2026-08-14T12:30:00Z
MARKHAM, Ontario, Aug. 14, 2026 (GLOBE NEWSWIRE) -- Sienna Senior Living Inc. (“Sienna” or the “Company”) (TSX: SIA) today announced a dividend of $0.078 per common share of the Company...
2026-08-14T12:30:00Z
– Receives FDA Conditional Approval of QYLEKI™ as the Proposed Brand Name for QRX003 for Netherton Syndrome
2026-08-14T12:30:00Z
BOSTON, Aug. 14, 2026 (GLOBE NEWSWIRE) -- Bicara Therapeutics Inc. (Nasdaq: BCAX), a clinical-stage biopharmaceutical company committed to bringing transformative bifunctional therapies to patients with solid tumors, today announced that,...
2026-08-14T12:30:00Z
HOUSTON, Aug. 14, 2026 (GLOBE NEWSWIRE) -- Moleculin Biotech, Inc., (Nasdaq: MBRX) (“Moleculin” or the “Company”), today reported financial results for the second quarter ended June 30, 2026, and highlighted...
2026-08-14T12:30:00Z
SALT LAKE CITY, Aug. 14, 2026 (GLOBE NEWSWIRE) -- Clene Inc. (Nasdaq: CLNN) today announced its second quarter 2026 financial results and provided recent updates on its CNM-Au8 programs.